bit.bio
Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development. The company uses a precision cell programming system to convert stem cells into defined human cell types and supplies a portfolio of reprogrammed cells, custom cell development services, and research-ready human cell models for scientific and pharmaceutical use. Bit.bio also supports integration of its products into partner research ecosystems and offers platform capabilities that help identify transcription factors for specific cell states. Its focus includes enabling scalable access to human cell models for experiments, screening workflows, and therapeutic investigation.
Domain
bit.bio
Country
United KingdomIndustry
BiotechnologyEmployees
101-250
Last Funding
$50.0M
Founded
2015
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does bit.bio use?+
bit.bio uses 17 technologies including HubSpot Chat, reCAPTCHA, Three.js.
What industry is bit.bio in?+
bit.bio operates in the Biotechnology industry.
Where is bit.bio based?+
bit.bio is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026